0      0

The Future of Manufacturing Quality in Pharma

‐ May 10, 2023 9:35am

St.Gallen works on the US FDA funded project “RiskSurve” which has just been extended to a second year. The project aims at developing a comprehensive site quality assessment based on machine learning models. Participants will understand how regulators approach site risk assessments and how to use data for risk and non-risk related decision-making.


You must be logged in and own this session in order to post comments.